Thermo Fisher Scientific | Actif À Court Terme



Current Assets Changement Date
Abbott USD 23.66B 146M 2024-12
Agilent USD 4.11B 148M 2025-01
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Bio Techne USD 634.64M 13.93M 2024-12
Bio-Rad Laboratories USD 3.03B 25.32M 2024-12
Boston Scientific USD 6.92B 1.84B 2024-12
Bruker USD 2.06B 133.1M 2024-12
Charles River Laboratories USD 1.4B 91.65M 2024-12
Danaher USD 9.5B 563M 2024-12
Dentsply International USD 1.75B 175M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Exact Sciences USD 1.57B 38.31M 2024-12
General Electric USD 37.64B 1.01B 2024-12
Henry Schein USD 3.98B 164M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Illumina USD 2.75B 373M 2024-12
Intuitive Surgical USD 11.54B 4.33B 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
Laboratory Of America USD 4.81B 103.4M 2024-12
Medtronic USD 22.51B 75M 2025-01
Mettler Toledo International USD 1.19B 4.33M 2024-12
Myriad Genetics USD 298M 4.8M 2024-12
Olympus JPY 647.39B 9.68B 2024-12
Patterson Companies USD 1.84B 4.38M 2025-01
Quest Diagnostics USD 2.39B 231M 2024-12
Repligen USD 1.13B 27.35M 2024-09
Revvity USD 2.35B 98.8M 2024-12
Stryker USD 14.85B 174M 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12
Veracyte USD 372.27M 15.41M 2024-12
Waters USD 1.67B 21.39M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Thermo Fisher Scientific Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.